Evidence map›Paper›PMID 40634828›Full record

ArticleAIDS and behavior2025

Development and Validation of a Novel Risk Calculator to Predict Sub-optimal HIV Outcomes Among Pregnant and Postpartum Women with HIV in Kenya.

Kevin Owuor, Janet M Turan, Jeff M Szychowski, Maricianah Onono, Linet Ongeri, Laura K Beres, Anna Helova, Emmah Ouma, Mercelline Onyando, Rena C Patel and 3 more

Abstract readValidation Study
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kevin OwuorDepartment of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA. kowuor@uab.edu.ORCID http://orcid.org/0000-0003-0712-3209
Janet M TuranSparkman Center for Global Health, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
Jeff M SzychowskiDepartment of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
Maricianah OnonoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Linet OngeriCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Laura K BeresDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Anna HelovaSparkman Center for Global Health, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
Emmah OumaCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Mercelline OnyandoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Rena C PatelDepartment of Infectious Diseases, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
Patrick OyaroHealth Innovations Kenya (HIK), Kisumu, Kenya.
Lisa L AbuogiDepartment of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Karen HampandaDepartment of Obstetrics and Gynecology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Achieving successful treatment outcomes among adolescents and pregnant/postpartum women living with HIV in KenyaK24AI175015 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Lisa Lynn Abuogi · 2023 to 2026
$762k
Piloting risk stratification and tailored interventions with pregnant and postpartum women with HIV in Kenya to prevent disengagement from care and viral failureR34MH126857 · NIMH · UNIVERSITY OF COLORADO DENVER · PI ABUOGI, LISA LYNN, ONONO, MARICIANAH ATIENO · 2022 to 2024
$629k
Optimizing viral suppression for pregnant and postpartum women living with HIV through HIV resistance testing (Opt4Mamasplus)R21AI145450 · NIAID · UNIVERSITY OF WASHINGTON · PI PATEL, RENA CHIMAN · 2019 to 2020
$453k
NIAID NIH HHS K24 AI175015NIAID NIH HHS P30 AI027757NIAID NIH HHS R21 AI145450NIMH NIH HHS R34 MH126857
6 · The paper itself

Abstract

No tool currently exists to predict the cumulative risk of suboptimal clinical outcomes among pregnant and postpartum women with HIV (PPWH). This study sought to develop and validate a parsimonious risk calculator capable of predicting disengagement from care and HIV treatment failure among PPWH. We created the risk calculator using data from 1,331 PPWH from Southwestern Kenya (Homabay, Migori, and Kisumu Counties) in the Mother Infant Visit Adherence and Treatment Engagement Trial. Least absolute shrinkage and selection operator logistic regression retained the most predictive variables from 16 candidate factors to estimate the probability of treatment failure or disengagement from care. Three risk quintiles were calculated. We assessed external validation with an independent dataset (Opt4Mamas; N = 820). Cross-validated area under the curve of receiver operating characteristic (AUROC) and calibration measures assessed model performance. Two unique risk calculators were created - one for PPWH with known HIV diagnosis prior to pregnancy and one for PPWH with new HIV diagnoses. The combined outcome of care disengagement or treatment failure occurred in 43% of PPWH with known diagnosis and 40% with new diagnosis in the development dataset; and 37% with known diagnosis and 13% with new diagnosis in the validation dataset. The calculators included demographic (age, parity, marital status), clinical (virological failure, missed visits, regimen line, gestation age), and psychosocial variables (intimate partner violence, stigma, depression, partner support, disclosure, food insecurity). The model for PPWH with known diagnosis demonstrated better calibration and discrimination (AUROC 0.843 [95% CI 0.805, 0.866]) than the model for PPWH with a new HIV diagnosis (AUROC 0.463 [95% CI 0.347, 0.597]). Mean predicted risk probabilities among PPWH with known HIV diagnosis were: low (6%), moderate (56%), and high (70%). Mean predicted risk probabilities among those with a new HIV diagnosis were: low (31%), moderate (48%), and high (65%). The novel risk calculator for PPWH with a known HIV diagnosis has the potential to identify those who are at risk of sub-optimal HIV treatment and care outcomes for targeted interventions to prevent treatment failure and loss to follow-up.

Indexed as

Anti-HIV AgentsHIV InfectionsPregnancy Complications, InfectiousAdultFemaleHumansInfectious Disease Transmission, VerticalKenyaLogistic ModelsPostpartum PeriodPregnancyRisk AssessmentRisk FactorsROC CurveTreatment FailureYoung AdultAnti-HIV AgentsCare DisengagementHIVPostpartumPregnantRiskVirologic Failure

Identifiers

PMID40634828
PMCPMC12335848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.